wrn inhibitor hro761
Generic: WRN Inhibitor HRO761
wrn inhibitor hro761: 1 clinical trial tracked.
wrn inhibitor hro761 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about wrn inhibitor hro761, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
An Open-label, Multi-center Phase I/Ib Dose Finding and Expansion Study of HRO761 as Single Agent and in Combinations in Patients With Microsatellite Instability-High or Mismatch Repair Deficient Advanced Solid Tumors.
Primary endpoint: Incidence and severity of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Interventionalopen123 targetStarted 2023-06Completion 2027-0828 sites · Belgium, China, France, Germany…Novartis Pharmaceuticals